Profiling of residual breast cancers after neoadjuvant chemotherapy identifies DUSP4 deficiency as a mechanism of drug resistance

Justin M. Balko, Rebecca S. Cook, David B. Vaught, María G. Kuba, Todd W. Miller, Neil E. Bhola, Melinda E. Sanders, Nara M. Granja-Ingram, J. Joshua Smith, Ingrid M. Meszoely, Janine Salter, Mitch Dowsett, Katherine Stemke-Hale, Ana M. González-Angulo, Gordon B. Mills, Joseph A. Pinto, Henry L. Gómez, Carlos L. Arteaga